ServiziMenu principaleHome
You are here:  > Educational Opportunities > Past events > 2023 > Refresher Course on Gynaecological Cancers
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page


Chairs:  I. Colombo, CH - A. Pasic, BA


The refresher course on gynaecological cancers has been designed for medical and clinical oncologists with the aim to provide an update on the -state of-the art therapeutic options as well as an overview of the latest advances in the field.
Practical training will be offered in the frame of clinical case presentations, prepared and presented by participants and discussed with the faculty.

Attendance to the course is limited and by application only. Priority will be given to applicants who have attended a previous ESO masterclass.

  • Update on the latest advances in diagnostic procedure
  • Update on the latest advances and on the state-of- the-art treatment options
  • Learn about the management of specific situations
  • Understand the pathology and molecular characteristics of gynecological cancer
  • Learn about the future development in the treatment of gynecological malignancies
  • Debate controversies and challenges in gynaecological cancer treatment
  • Improve practical skills in multidisciplinary management and follow-up of gynaecological cancer patients




The official language will be English. No translation will be available.


An application to the European Accreditation Council for Continuing Medical Education (EACCME) will be submitted to obtain CME credits for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net
Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

ESCO - The ESO College

Being selected to take part in this ESO activity gives participants eligibility to enrol in ESCO - the College of the European School of Oncology.
This event also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the event earns participants 9 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.


Attendance is limited to 30 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO masterclass.

Applicants should meet the following profile:

  • Age between 30 and 45 years
  • At least 2-3 years’ experience in medical oncology
  • Fluency in English

Successful applicants are granted free registration.

Accommodation at the course venue for arrival on 24th November and departure on the 26th November will be provided to participants not residing in the Sarajevo area.



Mariachiara Deleo

European School of Oncology (ESO)
Via Turati 29
IT- 20121 Milan

ph  +39 335 181 4541
email: mdeleo@eso.net

Dolores Knupfer
European School of Oncology (ESO)
Via Vicenzo Vela 6
CH- 6500 Bellinzona

ph +41 91 820 09 52
e-mail: dknupfer@eso.net




Interested candidates should apply online providing:

  • Application template
  • Abstract
  • Letter describing motivation for attending
  • Short CV (template) with the list of publications (if the list of publication is not provided, it will be assumed that no articles have been published)

If you are a past ESO Masterclass participant, you only need to submit the application template and abstract.


Applicants are requested to submit an abstract describing a clinical case related to gynecological cancer on one of the following cathegories:

  • Cervical
  • Endometrial
  • Ovarian

A selected number of admitted participants will have the opportunity to present their clinical case in the format of a clinical grand round discussion with the chairs, other faculty members and participants within plenary tumour board sessions in the programme. The application outcome will be notified by e-mail by the 13th October.


24 November

19:30Welcome dinner

25 November

8:15Welcome address and general introduction - His Excellency Marco Di Ruzza, Italian Ambassador to Bosnia and Herzegovina
Ilaria Colombo, CH - Anes Pasic, BA - Fedro Alessandro Peccatori, IT
 8:30Surgical approach for newly diagnosed and recurrent ovarian cancer
Andrej Cokan, SI
 9:00Germline and somatic molecular testing: indications and challenges
Ermina Iljazovic, BA
 9:30Systemic treatment of newly diagnosed ovarian cancer
Maja Ravnik, SI
 10:00Systemic treatment of recurrent ovarian cancer
Berisa Hasanbegovic, BA
10:30Coffee break
11:00Treatment of rare ovarian cancers
Ilaria Colombo, CH
11:30Tumour board – clinical cases presentations by participants
 13:30Optimal surgical treatment of early and advanced endometrial cancer
Andrej Cokan, SI
 14:00Molecular classification of endometrial cancer
Anes Pasic, BA
 14:30Adjuvant treatment of endometrial cancer
Alina Sturdza , AT
 15:00Treatment of locally advanced and metastatic endometrial cancer
Maja Ravnik, SI
15:30Coffee break
16:00Future perspectives in the treatment of ovarian and endometrial cancer
Ilaria Colombo, CH
16:30Tumour board – clinical cases presentations by participants

26 November

 8:15Diagnosis and prevention of cervical cancer
Vesna Kesic, RS
 8:45Optimal surgical treatment of patients with early and advanced cervical cancer
Michael Halaska, CZ
 9:15Hiba Basic Memorial Lecture: Management of locally advanced cervical cancer
Alina Sturdza , AT
 9:45Treatment of recurrent and metastatic cervical cancer
Anes Pasic, BA
10:15Coffee break
10:30Fertility-sparing surgery in gynecological cancers
Michael Halaska, CZ
11:00Tumour board – clinical cases presentations by participants
12:00Closing remarks
Ilaria Colombo, CH - Anes Pasic, BA - Fedro Alessandro Peccatori, IT


Andrej Cokan, University Medical Centre Maribor, Gynaecological and Breast Cancer Dpt., Maribor, SI
Ilaria Colombo, Oncology Institute of Southern Switzerland, EOC, Oncology Dpt., Bellinzona, CH
Michael Halaska, Charles University, Dept. of Obstetrics and Gynecology, Prague, CZ
Berisa Hasanbegovic, Clinical Center University of Sarajevo, Oncology Dept., Sarajevo, BA
Ermina Iljazovic, University Clinical Center Tuzla, Dept. of Pathology, Tuzla, BA
Vesna Kesic, University of Belgrade, Clinic for Obstetrics and Gynecology, Clinical Center of Serbia, Belgrade, RS
Anes Pasic, Clinical Center University of Sarajevo, Oncology Dept., Sarajevo, BA
Fedro Alessandro Peccatori, European Institute of Oncology, Dept. of Fertility and Procreation in Oncology, Milano, IT
Maja Ravnik, University Medical Centre Maribor, Department of Oncology, Maribor, SI
Alina Sturdza, Comprehensive Cancer Center, Medical University of Vienna, Department of Radiation Oncology, Vienna, AT